It is not uncommon for people in recovery to experience depression and/or other mental health problems. While addiction and depression are closely linked, one does not directly cause the other, and research has demonstrated that both conditions can exist simultaneously. Alcohol and drugs are often used to self-medicate the symptoms of depression or anxiety. It is normal for addicts who achieve sobriety to continue to feel miserable and have a difficult time in their recovery. Experts estimate that one-third of all substance abusers suffer from some kind of depressive disorder.
Ketamine therapy brings new hope for those suffering from depression – and gives everyone, including those in recovery, a chance to enjoy life more fully. Low-dose IV infusion Ketamine has been called the most significant advancement in mental health treatment in the past 50 years. If you or a loved one are struggling with depression, even debilitating, treatment-resistant depression that drains your energy and deprives you of the life that you deserve, Ketamine therapy is likely to help.
Since 2006, studies have shown that this safe and innovative treatment can reverse the kind of severe depression that is often treated with traditional antidepressants. This is crucial information, as people who are in addiction recovery are far more likely to relapse if they are depressed. Approximately 75% of patients with depression or anxiety experience a significant mood improvement following one to four intravenous Ketamine infusions. A key advantage for Ketamine therapy is its rapid effect compared to other antidepression medications; many patients go from depressed to well in a single day. Additionally, one of the benefits of Ketamine therapy is that a single treatment can last from 25 days to eight months.
How Does It Work?
While experts are still learning about how Ketamine works, they do know that it works differently than other commonly used antidepressants, such as Prozac, Zoloft or Effexor. In general, Ketamine infusion activates certain neurotransmitter receptors and pathways which trigger rapid growth of new neurological connections. Researchers believe that prolonged exposure to stress causes certain neurons to die off, resulting in depression. Ketamine causes these neurons to rapidly regenerate within hours, relieving the depressive symptoms.
There is speculation that depression results from a change in the original blueprint of neurological brain connections due to damage or misconnections of certain critical synapses, and that Ketamine detaches the improper synapses, allowing them to regenerate and reattach according to the original non-depression blueprint. Ketamine is also a powerful anti-inflammatory medication. Since depression has been linked to chronic inflammation, this may also be part of its antidepressant effect. Research shows that 70 to 80% of patients have experienced significant relief for treatment of depression using Ketamine infusions.
Ketamine Study Summary
An article in the Journal of Neuropharmacology summarized 25 peer-reviewed studies that examined Ketamine therapy for people with depression. Every one of these studies suggested that Ketamine was indeed an “active and rapid antidepressant” for people with treatment-resistant depression. Some of those studies showed that Ketamine also reduced thoughts of suicide in depressed subjects. In addition, low-dose Ketamine infusions have not been shown to be addictive.
Can your recovery experience be improved? Are you, or is someone you love, struggling with debilitating depression? Rediscover the joy of sobriety. Find a qualified physician or psychiatrist and discover whether you might be a candidate for Ketamine treatment.
Note: According to WebMD, Ketamine therapy has been placed on a fast track for FDA approval for the treatment of depression.
Jason Babcock, MBA, CMPE, is the Practice Administrator and CEO of Arizona Ketamine Treatment and Research. He has over 25 years of healthcare administration experience with a strong background in finance, business development, operational improvement, marketing and customer service to AKTARI. Babcock has a master’s degree in healthcare administration and is an active member of the Medical Group Managers Association and the American Academy of Professional Coders. He is also a Certified Medical Practice Executive with the American College of Medical Practice Executives.